igf-1-lr3-gmp Recombinant Human LR3 IGF-I/IGF-1 GMP Protein, CF 8335D-GMP: R&D Systems QK041 - Recombinant human/bovine/porcine IGF-1

Funding This research was funded by the National Academy of Sciences of Ukraine, state registration number 0124U002425

The immunopeptidome of the senescent phenotype is associated with 70 peptides which makes senescent cells immunogenic and potentially targetable by immune cells

Because the results depend heavily on the exact treatment settings (waveform, intensity, frequency, and duration), it is important for clinicians to carefully document the treatment plan and base recommendations on high-quality research whenever possible

Potential cellular targets and antibacterial efficacy of atmospheric pressure non-thermal plasma